cost-effectiveness of tipranavir versus comparator protease inhibitor regimens in hiv infected patients previously exposed to antiretroviral therapy in the netherlands成本效益tipranavir与比较器的蛋白酶抑制剂方案此前接触过抗逆转录病毒治疗的艾滋病毒感染者在荷兰.pdfVIP

  • 3
  • 0
  • 约6.04万字
  • 约 9页
  • 2017-09-06 发布于上海
  • 举报

cost-effectiveness of tipranavir versus comparator protease inhibitor regimens in hiv infected patients previously exposed to antiretroviral therapy in the netherlands成本效益tipranavir与比较器的蛋白酶抑制剂方案此前接触过抗逆转录病毒治疗的艾滋病毒感染者在荷兰.pdf

cost-effectiveness of tipranavir versus comparator protease inhibitor regimens in hiv infected patients previously exposed to antiretroviral therapy in the netherlands成本效益tipranavir与比较器的蛋白酶抑制剂方案此前接触过抗逆转录病毒治疗的艾滋病毒感染者在荷兰

Cost Effectiveness and Resource Allocation BioMed Central Research Open Access Cost-effectiveness of tipranavir versus comparator protease inhibitor regimens in HIV infected patients previously exposed to antiretroviral therapy in the Netherlands 1 1

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档